EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.7.1.17 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate + H2O |
- |
Mycobacterium tuberculosis |
? |
- |
? |
3.7.1.17 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate + H2O |
- |
Mycobacterium tuberculosis H37Rv |
? |
- |
? |
3.7.1.17 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid + H2O |
- |
Mycobacterium tuberculosis |
? |
- |
? |
3.7.1.17 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid + H2O |
- |
Mycobacterium tuberculosis H37Rv |
? |
- |
? |
3.7.1.17 | 4,5-9,10-diseco-3-hydroxy-5,9,17-tri-oxoandrosta-1(10),2-diene-4-oic acid + H2O |
best substrate |
Mycobacterium tuberculosis |
9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid + 2-hydroxy-hexa-2,4-dienoic acid |
- |
? |
3.7.1.17 | 4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-dien-4-oic acid + H2O |
- |
Comamonas testosteroni |
9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid + 2-hydroxyhexa-2,4-dienoic acid |
- |
? |
3.7.1.17 | 4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-dien-4-oic acid + H2O |
- |
Comamonas testosteroni TA441 |
9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid + 2-hydroxyhexa-2,4-dienoic acid |
- |
? |
3.7.1.17 | 4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oic acid + H2O |
high specificity |
Mycobacterium tuberculosis |
? |
- |
? |
3.7.1.17 | 4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oic acid + H2O |
high specificity |
Mycobacterium tuberculosis H37Rv |
? |
- |
? |
3.7.1.17 | 4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oic acid + H2O |
the apparent specificity for 4,59,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oic acid is 34fold higher than for 2-hydroxy-6-oxo-6-phenylpentadienoate |
Mycobacterium tuberculosis |
9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid + ? |
- |
? |